Vivanza Biosciences consolidated net profit rises 2700.00% in the September 2025 quarter

Sales rise 1745.33% to Rs 55.36 crore
Net profit of Vivanza Biosciences rose 2700.00% to Rs 0.56 crore in the quarter ended September 2025 as against Rs 0.02 crore during the previous quarter ended September 2024. Sales rose 1745.33% to Rs 55.36 crore in the quarter ended September 2025 as against Rs 3.00 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales55.363.00 1745 OPM %1.083.67 -PBDT0.570.02 2750 PBT0.560.02 2700 NP0.560.02 2700Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 12 2025 | 7:42 AM IST
